Eiko Lifesciences informs about revised disclosures

17 May 2022 Evaluate

Eiko Lifesciences has informed that the Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF.

The above information is a part of company’s filings submitted to BSE.

Eiko Lifesciences Share Price

50.87 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1080.00
SRF 2288.80
Pidilite Inds. 3003.20
Aarti Inds 631.90
Gujarat Fluorochemic 3236.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.